EVANGELIA KRANIAS

EVANGELIA KRANIAS

University of Cincinnati

H-index: 96

North America-United States

About EVANGELIA KRANIAS

EVANGELIA KRANIAS, With an exceptional h-index of 96 and a recent h-index of 37 (since 2020), a distinguished researcher at University of Cincinnati, specializes in the field of CARDIAC, CALCIUM, HEART FAILURE, GENETIC MUTATIONS.

His recent articles reflect a diverse array of research interests and contributions to the field:

A novel role for phospholamban in the thalamic reticular nucleus

Unleashing the Power of Genetics: PLN Ablation, Phospholambanopathies and Evolving Challenges

Myofilament alterations associated with human R14del-phospholamban cardiomyopathy

Isoform changes of action potential regulators in the ventricles of arrhythmogenic phospholamban-R14del humanized mouse hearts

Phospholamban R14del disease: The past, the present and the future

Modulating phosphatase activity in cardiac cells

A first-in-human phase 1 clinical gene therapy trial for the treatment of heart failure using a novel rationally designed cardiotropic adeno-associated vector

In Memoriam Tribute to Jeffrey Robbins, PhD (1950–2022)

EVANGELIA KRANIAS Information

University

University of Cincinnati

Position

___

Citations(all)

30467

Citations(since 2020)

5486

Cited By

26634

hIndex(all)

96

hIndex(since 2020)

37

i10Index(all)

294

i10Index(since 2020)

146

Email

University Profile Page

University of Cincinnati

EVANGELIA KRANIAS Skills & Research Interests

CARDIAC

CALCIUM

HEART FAILURE

GENETIC MUTATIONS

Top articles of EVANGELIA KRANIAS

Title

Journal

Author(s)

Publication Date

A novel role for phospholamban in the thalamic reticular nucleus

Scientific Reports

Benjamin Klocke

Aikaterini Britzolaki

Joseph Saurine

Hayden Ott

Kylie Krone

...

2024/3/16

Unleashing the Power of Genetics: PLN Ablation, Phospholambanopathies and Evolving Challenges

Circulation Research

Alicia Mattiazzi

Evangelia G Kranias

2024/1/19

Myofilament alterations associated with human R14del-phospholamban cardiomyopathy

International Journal of Molecular Sciences

Mohit Kumar

Kobra Haghighi

Sheryl Koch

Jack Rubinstein

Francesca Stillitano

...

2023/1/31

Isoform changes of action potential regulators in the ventricles of arrhythmogenic phospholamban-R14del humanized mouse hearts

Metabolism

Malgorzata E Rogalska

Elizabeth Vafiadaki

Zoi Erpapazoglou

Kobra Haghighi

Lisa Green

...

2023/1/1

Phospholamban R14del disease: The past, the present and the future

Elizabeth Vafiadaki

Pieter C Glijnis

Pieter A Doevendans

Evangelia G Kranias

Despina Sanoudou

2023/4/18

Modulating phosphatase activity in cardiac cells

2022/1/4

A first-in-human phase 1 clinical gene therapy trial for the treatment of heart failure using a novel rationally designed cardiotropic adeno-associated vector

Journal of Molecular and Cellular Cardiology

Monica Alvisi

Timothy Henry

Eugene Chung

Jay Traverse

Leigh Ervin

...

2022/12/31

In Memoriam Tribute to Jeffrey Robbins, PhD (1950–2022)

Sakthivel Sadayappan

Evangelia G Kranias

2022/11/11

Gene editing reverses arrhythmia susceptibility in humanized PLN-R14del mice: modelling a European cardiomyopathy with global impact

Cardiovascular Research

Jaydev Dave

Nour Raad

Nishka Mittal

Lu Zhang

Anthony Fargnoli

...

2022/11/1

Aberrant PLN-R14del Protein Interactions Intensify SERCA2a Inhibition, Driving Impaired Ca2+ Handling and Arrhythmogenesis

International Journal of Molecular Sciences

Elizabeth Vafiadaki

Kobra Haghighi

Demetrios A Arvanitis

Evangelia G Kranias

Despina Sanoudou

2022/6/22

Abstract P482: Elucidating and Characterizing the Molecular Mechanistic Role of Phospholamban L39 Stop in the Pathophysiology of Cardiomyopathy Using Patient-derived Human …

Circulation Research

Anichavezhi Devendran

Rasheed Bailey

Sumanta Kar

Francesca Stillitano

Irene Turnbull

...

2021/9/3

Arrhythmia mechanism and dynamics in a humanized mouse model of inherited cardiomyopathy caused by phospholamban R14del mutation

Circulation

Nour Raad

Philip Bittihn

Marine Cacheux

Dongtak Jeong

Zeki Ilkan

...

2021/8/10

Impaired right ventricular calcium cycling is an early risk factor in R14del-phospholamban arrhythmias

Journal of Personalized Medicine

Kobra Haghighi

George Gardner

Elizabeth Vafiadaki

Mohit Kumar

Lisa C Green

...

2021/6/3

Stress seats a new guest at the table of PLN/SERCA and their partners

Alicia Mattiazzi

Jil C Tardiff

Evangelia G Kranias

2021/2/19

The cardioprotective PKA-mediated Hsp20 phosphorylation modulates protein associations regulating cytoskeletal dynamics

International Journal of Molecular Sciences

Elizabeth Vafiadaki

Demetrios A Arvanitis

Aristides G Eliopoulos

Evangelia G Kranias

Despina Sanoudou

2020/12/16

Hepatic HAX-1 inactivation prevents metabolic diseases by enhancing mitochondrial activity and bile salt export

Journal of Biological Chemistry

Fawzi Alogaili

Sivaprakasam Chinnarasu

Anja Jaeschke

Evangelia G Kranias

David Y Hui

2020/4/3

Determinants of Ca2+ release restitution: Insights from genetically altered animals and mathematical modeling

Journal of general physiology

Alejandra Cely-Ortiz

Juan I Felice

Leandro A Díaz-Zegarra

Carlos A Valverde

Marilén Federico

...

2020/9/28

Probenecid treatment improves outcomes in a novel mouse model of peripartum cardiomyopathy

PLoS One

Evan Onusko

Michael R McDermott

Nathan Robbins

Guansheng Liu

Evangelia G Kranias

...

2020/3/27

Phosphorylation of cardiac myosin–binding protein-C contributes to calcium homeostasis

Journal of Biological Chemistry

Mohit Kumar

Kobra Haghighi

Evangelia G Kranias

Sakthivel Sadayappan

2020/8/7

Modifications of sarcoplasmic reticulum function prevent progression of sarcomere-linked hypertrophic cardiomyopathy despite a persistent increase in myofilament calcium response

Frontiers in Physiology

Shamim AK Chowdhury

Chad M Warren

Jillian N Simon

David M Ryba

Ashley Batra

...

2020/3/10

See List of Professors in EVANGELIA KRANIAS University(University of Cincinnati)

EVANGELIA KRANIAS FAQs

What is EVANGELIA KRANIAS's h-index at University of Cincinnati?

The h-index of EVANGELIA KRANIAS has been 37 since 2020 and 96 in total.

What are EVANGELIA KRANIAS's top articles?

The articles with the titles of

A novel role for phospholamban in the thalamic reticular nucleus

Unleashing the Power of Genetics: PLN Ablation, Phospholambanopathies and Evolving Challenges

Myofilament alterations associated with human R14del-phospholamban cardiomyopathy

Isoform changes of action potential regulators in the ventricles of arrhythmogenic phospholamban-R14del humanized mouse hearts

Phospholamban R14del disease: The past, the present and the future

Modulating phosphatase activity in cardiac cells

A first-in-human phase 1 clinical gene therapy trial for the treatment of heart failure using a novel rationally designed cardiotropic adeno-associated vector

In Memoriam Tribute to Jeffrey Robbins, PhD (1950–2022)

...

are the top articles of EVANGELIA KRANIAS at University of Cincinnati.

What are EVANGELIA KRANIAS's research interests?

The research interests of EVANGELIA KRANIAS are: CARDIAC, CALCIUM, HEART FAILURE, GENETIC MUTATIONS

What is EVANGELIA KRANIAS's total number of citations?

EVANGELIA KRANIAS has 30,467 citations in total.